Article
While comorbidities are associated with severe COVID-19 infection, it appears they also influence severity and survival in rheumatic disease (RMD), according to a a French cohort study,
All News
Article
Among children with multisystem inflammatory syndrome (MIS-C), treatment with IVIG and methylprednisolone vs IVIG alone was associated with a more favorable fever course. MIS-C is a rare but serious pediatric condition associated with COVID-19 where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.
Article
Knee osteoarthritis (OA) patients using nonsteroidal anti-inflammatory drugs (NSAIDs) showed greater loss of medial minimum joint space width than did others taking other drugs, registry data indicated.
Dr. John Cush
Tweet
We are excited to announce that Dr. Eric Ruderman ( @JointMD) will be speaking on advancing treatments in psoriatic arthritis at RheumNow Live, March 20-21. There's still time to sign up. https://t.co/vJlU0Z3Q3x https://t.co/T0V8JIygyA
Rheumatology Advisor
Tweet
Text mining of #EHRs can be used to accurately identify and characterize patients with #SLE #Lupus #Rheumatology #RheumTwitter
https://t.co/JayhTRRPz9
Juan Carlos Nieto
Tweet
Adherencia a fármacos biológicos subcutáneos en enfermedades inflamatorias (artritis crónicas y enfermedades inflamatorias intestinales).
Contento del resultado de nuestr Revisión Sistemática 🦾
@carmona_loreto https://t.co/Elmc61BE6d
Dr. John Cush
Tweet
Hydroxychloroquine Fails to Prevent COVID-19 The NEJM reports the results of a trial where HCQ given as post-COVID exposure therapy failed to prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons. https://t.co/lt71GAtL3D https://t.co/9OyUpQBpzL
Dr. John Cush
Tweet
402 RA pts in RA-Paz registry, starting bDMARD betw 2000 - 2019, had 10% refractory to multiple biologics. Difficult or multi-biologic refractory Dz predicted by erosions, younger age, high baseline DAS-28, unable to lower DAS < 1.2 @6 mo (OR 11.1) https://t.co/GYJ69dgCtr
Dr. John Cush
Tweet
Between March - Oct 2020, 10 US states with mask mandates reported a 4.9% decline in weekly COVID-19 hospitalizations, significant for those under 65 yrs (5.5%). Results most notable > 3 weeks after the mask mandate. https://t.co/umjiFVNACF
Dr. John Cush
Tweet
Johns Hopkins & UCSF Scleroderma pts tested for Abs against telomerase & shelterin (TERF1); while rare in RA, myositis, controls; TERF1 Abs seen in 9% of SSc & assoc w/ severe lung disease (OR 2.4) & shorter telomere length. (TERF1 found in 7% of IPF) https://t.co/e5ai8uO4kK
Dr. John Cush
Tweet
Abrupt Cessation of Long-Term Opioid Prescribing Common
Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed.
https://t.co/bCnaJHECd0 https://t.co/PfM9BCNPyC
Dr. John Cush
Tweet
Cardiac and Cancer Signals Tofacitinib Safety Alert from FDA
The FDA has notified healthcare professionals of a safety alert concerning tofacitinib when given to at-risk RA patients.
https://t.co/RJD8CMouHK https://t.co/j8DMyxsaaf
Dr. John Cush
Tweet
Bimekizumab, a bispecific mAb inhibits IL-7F & IL-17A, was testedin PhIII trial in Active psoriasis and show to be more effective than ustekinumab and placebo. 567 PSO pts - at wk 16, PASI90 was BMKZ 85% vs Ustekinumab 50%, vs 5% in placeob (p<0·0001) https://t.co/Z4ZQEHO4rX
Dr. John Cush
Tweet
Vagal Nerve Stimulation in Rheumatoid Arthritis
Lancet Rheumatology has reported the results of a proof of concept trial, wherein vagal nerve stimulation was shown to ameliorate rheumatoid arthritis (RA) disease activity.
https://t.co/XKH0ZY2A7E https://t.co/41nIxMb3e6
Dr. John Cush
Tweet
QD Clinic Podcast from Last week. iTunes https://t.co/FHJv01AAbC or SoundCloud https://t.co/dfSTkSbY2d
QD Clinics (123-127; Feb 5)
QD127 - Chronic Monarthritis
QD126 - Fever by the Numbers
QD125 - "What Were You Thinking"
QD124 - No Win Consults
QD123 - When RA Meets UC https://t.co/ReOFOVooje
Dr. John Cush
Tweet
UK Biobank examined the association between comorbidities & uric acid (SUA). Comorbidities assoc w/ increasing SUA. For each 1 mg increase in SUA, there is a 1-3 fold incr risk of HTN, IHD, CCF, ^HL, CKD https://t.co/ZEPAPRq62k
Dr. John Cush
Tweet
RheumNow Podcast is up! Tofacitinib Safety Concerns - covering vagal nerve stimulation, IL-23 in PsA, Diet & RA, NSAIDs & COVID, Plaquenil side effects and more. Watch it here>> https://t.co/7RDZ0avZLC ListeniTunes>>https://t.co/FHJv01AAbC or SoundCloud>>https://t.co/yJWJNa6CRL
Dr. John Cush
Tweet
QD Clinic - Chronic Monarthritis
Treatment Considerations on Chronic Monarthritis
https://t.co/7VmH1skHhb
Dr. John Cush
Tweet
Download available--30 FDA Approved Biologics in Rheumatology
https://t.co/HSvllkDUz7
Dr. John Cush
Tweet
Abrupt Cessation of Long-Term Opioid Prescribing Common
Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed.
https://t.co/bCnaJHECd0 https://t.co/ermkbK6LMN
